GMO U.S. Quality ETF
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company.
AI analysis
An AI analyst reads GMO U.S. Quality ETF's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
News
Top 3 Quality Stocks To Watch In November 2026Yahoo Finance · Nov 8, 20263 Great Quality Stocks To Watch In November 2026Yahoo Finance · Nov 1, 20263 High Quality Stocks With ROE Over 30%Yahoo Finance · Oct 25, 2026Alibaba shares tumble as China presses e-commerce platforms on quality standardsSeeking Alpha · Oct 22, 2026Dividend Aristocrats or Quality Factor: Which ETF Fits Retirement?Yahoo Finance · Oct 19, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about GMO U.S. Quality ETF
Is GMO U.S. Quality ETF a good stock to buy?
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the GMO U.S. Quality ETF AI analysis
What does GMO U.S. Quality ETF do?
The fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing primarily in equities of U.S. companies that the fund’s adviser, Grantham, Mayo, Van Otterloo & Co. LLC (“GMO” or the “Adviser”), believes to be of high quality. It is in Asset Management.
How has GMO U.S. Quality ETF stock done over the past year?
Up 18.4% over the past twelve months, to $44.47. It traded between $35.27 and $44.86, close to its high.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.